{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:37:56Z","timestamp":1767173876104,"version":"build-2238731810"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Gen Psychiatry"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12991-016-0109-z","type":"journal-article","created":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T07:49:27Z","timestamp":1480060167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The newer Opioid Agonist Treatment with lower substitutive opiate doses is associated with better toxicology outcome than the older Harm Reduction Treatment"],"prefix":"10.1186","volume":"15","author":[{"given":"Jacopo V.","family":"Bizzarri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Casetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livia","family":"Sanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo Giovanni Icro","family":"Maremmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Rovai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Bacciardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daria","family":"Piacentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Conca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Icro","family":"Maremmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,25]]},"reference":[{"issue":"13","key":"109_CR1","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","volume":"284","author":"AT McLellan","year":"2000","unstructured":"McLellan AT, Lewis DC, O\u2019Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284(13):1689\u201395.","journal-title":"JAMA"},{"key":"109_CR2","unstructured":"UNODC. World drug report 2014. 2014. www.unodcorg\/unodc\/indexhtml?ref=menutop . Accessed 28 July 2010."},{"key":"109_CR3","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). http:\/\/www.emcdda.europa.eu\/countries\/italy . Accessed 3 Apr 2010."},{"key":"109_CR4","unstructured":"WHO. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. 2009. www.who.int . Accessed 28 May 2010."},{"issue":"9","key":"109_CR5","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/j.1360-0443.2011.03463.x","volume":"106","author":"J Reimer","year":"2011","unstructured":"Reimer J, Verthein U, Karow A, Schafer I, Naber D, Haasen C. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial. Addiction. 2011;106(9):1647\u201355.","journal-title":"Addiction"},{"issue":"1","key":"109_CR6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","volume":"106","author":"L Degenhardt","year":"2011","unstructured":"Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M, McLaren J. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction. 2011;106(1):32\u201351.","journal-title":"Addiction"},{"issue":"5","key":"109_CR7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/0004867010060507","volume":"35","author":"T Callaly","year":"2001","unstructured":"Callaly T, Trauer T, Munro L, Whelan G. Prevalence of psychiatric disorder in a methadone maintenance population. Aust N Z J Psychiatry. 2001;35(5):601\u20135.","journal-title":"Aust N Z J Psychiatry"},{"key":"109_CR8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neuroscience.2013.04.034","volume":"248","author":"JL Scavone","year":"2013","unstructured":"Scavone JL, Sterling RC, Van Bockstaele EJ. Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal. Neuroscience. 2013;248:637\u201354.","journal-title":"Neuroscience"},{"key":"109_CR9","unstructured":"Maremmani I, Pacini M, Pani PP, on behalf of the \u2018Basics on Addiction Group\u2019. Basics on addiction: a training package for medical practitioners or psychiatrists who treat opioid dependence. Heroin Addict Relat Clin Probl. 2011;13(2):5\u201340. http:\/\/www.heroinaddictionrelatedclinicalproblems.org\/harcp-archives.php?year=2011 ."},{"key":"109_CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1747-597X-9-13","volume":"9","author":"J Reimer","year":"2014","unstructured":"Reimer J, Boniakowski E, Bachner C, Weber B, Tietje W, Verthein U, Walcher S. When higher doses in opioid replacement treatment are still inadequate\u2014association to multidimensional illness severity: a cohort study. Subst Abuse Treat Prev Policy. 2014;9:13.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"109_CR11","doi-asserted-by":"crossref","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2003(2):CD002209. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12804430 .","DOI":"10.1002\/14651858.CD002209"},{"issue":"9631","key":"109_CR12","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/S0140-6736(08)60954-X","volume":"371","author":"RS Schottenfeld","year":"2008","unstructured":"Schottenfeld RS, Chawarski MC, Mazlan M. Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371(9631):2192\u2013200.","journal-title":"Lancet"},{"key":"109_CR13","unstructured":"Maremmani I, Pacini M, Lubrano S, Giuntoli G, Lovrecic M. Harm reduction and specific treatments for heroin addiction. Different approaches or levels of intervention? An illness-centred perspective. Heroin Addict Relat Clin Probl. 2002;4(3):5\u201311. http:\/\/www.heroinaddictionrelatedclinicalproblems.org\/harcp-archives.php?year=2002 ."},{"key":"109_CR14","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1360-0443.1994.tb00977.x","volume":"89","author":"B Wells","year":"1994","unstructured":"Wells B. Methadone maintenance treatment: harm reduction or rehabilitation? Addiction. 1994;89:806.","journal-title":"Addiction"},{"key":"109_CR15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/archinte.1966.00290160004002","volume":"118","author":"VP Dole","year":"1966","unstructured":"Dole VP, Nyswander ME, Kreek MJ. Narcotic blockade. Arch Intern Med. 1966;118:304\u20139.","journal-title":"Arch Intern Med"},{"key":"109_CR16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archinte.1967.00300010021004","volume":"120","author":"VP Dole","year":"1967","unstructured":"Dole VP, Nyswander ME. Heroin addiction. A metabolic disease. Arch Intern Med. 1967;120:19\u201324.","journal-title":"Arch Intern Med"},{"key":"109_CR17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-3-7091-6901-8_6","volume-title":"Drug addiction and related clinical problems","author":"VP Dole","year":"1995","unstructured":"Dole VP. Methadone maintenance. Comes of age. In: Tagliamonte A, Maremmani I, editors. Drug addiction and related clinical problems. New York: Springer-Verlag; 1995. p. 45\u20139."},{"key":"109_CR18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/09595239800187011","volume":"2","author":"S Lenton","year":"1998","unstructured":"Lenton S, Single E. The definition of harm reduction. Drug Alcohol Rev. 1998;2:213\u20139.","journal-title":"Drug Alcohol Rev"},{"issue":"5","key":"109_CR19","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2105\/AJPH.91.5.774","volume":"91","author":"MW Langendam","year":"2001","unstructured":"Langendam MW, Van Brussel GH, Coutinho RA, Van Ameijden EJ. The impact of harm-reduction-based methadone treatment on mortality among heroin users. Am J Public Health. 2001;91(5):774\u201380.","journal-title":"Am J Public Health"},{"issue":"3","key":"109_CR20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000092113","volume":"12","author":"F Schifano","year":"2006","unstructured":"Schifano F, Bargagli AM, Belleudi V, Amato L, Davoli M, Diecidue R, Versino E, Vigna-Taglianti F, Faggiano F, Perucci CA. Methadone treatment in clinical practice in Italy: need for improvement. Eur Addict Res. 2006;12(3):121\u20137.","journal-title":"Eur Addict Res"},{"issue":"12","key":"109_CR21","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.3109\/10826081003791932","volume":"45","author":"G Salamina","year":"2010","unstructured":"Salamina G, Diecidue R, Vigna-Taglianti F, Jarre P, Schifano P, Bargagli AM, Davoli M, Amato L, Perucci CA, Faggiano F. Effectiveness of therapies for heroin addiction in retaining patients in treatment: results from the VEdeTTE study. Subst Use Misuse. 2010;45(12):2076\u201392.","journal-title":"Subst Use Misuse"},{"issue":"2","key":"109_CR22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0376-8716(98)00091-X","volume":"52","author":"D D\u2019Ippoliti","year":"1998","unstructured":"D\u2019Ippoliti D, Davoli M, Perucci CA, Pasqualini F, Bargagli AM. Retention in treatment of heroin users in Italy: the role of treatment type and of methadone maintenance dosage. Drug Alcohol Depend. 1998;52(2):167\u201371.","journal-title":"Drug Alcohol Depend"},{"key":"109_CR23","doi-asserted-by":"crossref","unstructured":"Faggiano F, Vigna-Taglianti F, Versino E, Lemma P. Methadone maintenance at different dosages for opioid dependence. Cochrane Database Syst Rev 2003;3:CD002208. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12917925 .","DOI":"10.1002\/14651858.CD002208"},{"issue":"3","key":"109_CR24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1300\/J069v24n03_03","volume":"24","author":"TM Brady","year":"2005","unstructured":"Brady TM, Salvucci S, Sverdlov LS, Male A, Kyeyune H, Sikali E, DeSale S, Yu P. Methadone dosage and retention: an examination of the 60\u00a0mg\/day threshold. J Addict Dis. 2005;24(3):23\u201347.","journal-title":"J Addict Dis"},{"issue":"6","key":"109_CR25","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1111\/j.1475-6773.2008.00870.x","volume":"43","author":"HA Pollack","year":"2008","unstructured":"Pollack HA, D\u2019Aunno T. Dosage patterns in methadone treatment: results from a national survey, 1988\u20132005. Health Serv Res. 2008;43(6):2143\u201363.","journal-title":"Health Serv Res"},{"key":"109_CR26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1477-7517-9-20","volume":"9","author":"J Dooley","year":"2012","unstructured":"Dooley J, Asbridge M, Fraser J, Kirkland S. Physicians\u2019 attitudes towards office-based delivery of methadone maintenance therapy: results from a cross-sectional survey of nova scotia primary-care physicians. Harm Reduct J. 2012;9:20.","journal-title":"Harm Reduct J"},{"issue":"2","key":"109_CR27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1753-6405.2001.tb01832.x","volume":"25","author":"M Lenne","year":"2001","unstructured":"Lenne M, Lintzeris N, Breen C, Harris S, Hawken L, Mattick R, Ritter A. Withdrawal from methadone maintenance treatment: prognosis and participant perspectives. Aust N Z J Public Health. 2001;25(2):121\u20135.","journal-title":"Aust N Z J Public Health"},{"issue":"25","key":"109_CR28","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJM196906192802502","volume":"280","author":"VP Dole","year":"1969","unstructured":"Dole VP, Robinson JW, Orraca J, Towns E, Searcy P, Caine E. Methadone treatment of randomly selected criminal addicts. N Engl J Med. 1969;280(25):1372\u20135.","journal-title":"N Engl J Med"},{"issue":"2","key":"109_CR29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11606-006-0258-x","volume":"21","author":"LR Gowing","year":"2006","unstructured":"Gowing LR, Farrell M, Bornemann R, Sullivan LE, Ali RL. Brief report: methadone treatment of injecting opioid users for prevention of HIV infection. J Gen Intern Med. 2006;21(2):193\u20135.","journal-title":"J Gen Intern Med"},{"issue":"3","key":"109_CR30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1600-0447.1990.tb03057.x","volume":"82","author":"L Gronbladh","year":"1990","unstructured":"Gronbladh L, Ohlund LS, Gunne LM. Mortality in heroin addiction: impact of methadone treatment. Acta Psychiatr Scand. 1990;82(3):223\u20137.","journal-title":"Acta Psychiatr Scand"},{"issue":"8141","key":"109_CR31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(79)91550-2","volume":"2","author":"RG Newman","year":"1979","unstructured":"Newman RG, Whitehill WB. Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong. Lancet. 1979;2(8141):485\u20138.","journal-title":"Lancet"},{"issue":"15","key":"109_CR32","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1001\/jama.1993.03500150065028","volume":"269","author":"AT McLellan","year":"1993","unstructured":"McLellan AT, Arndt IO, Metzger DS, Woody GE, O\u2019Brien CP. The effects of psychosocial services in substance abuse treatment. JAMA. 1993;269(15):1953\u20139.","journal-title":"JAMA"},{"issue":"1\u20133","key":"109_CR33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.drugalcdep.2012.10.025","volume":"130","author":"AP Kennedy","year":"2013","unstructured":"Kennedy AP, Phillips KA, Epstein DH, Reamer DA, Schmittner J, Preston KL. A randomized investigation of methadone doses at or over 100\u00a0mg\/day, combined with contingency management. Drug Alcohol Depend. 2013;130(1\u20133):77\u201384.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"109_CR34","first-page":"23","volume":"14","author":"A Dale-Perera","year":"2012","unstructured":"Dale-Perera A, Goul\u00e3o J, St\u00f6ver H. Quality of care provided to patients receiving opioid maintenance treatment in Europe: results from the EQUATOR analysis. Heroin Addict Relat Clin Probl. 2012;14(4):23\u201338.","journal-title":"Heroin Addict Relat Clin Probl"},{"issue":"3","key":"109_CR35","first-page":"5","volume":"14","author":"G Fischer","year":"2012","unstructured":"Fischer G, St\u00f6ver H. Assessing the current state of opioid-dependence treatment across Europe: methodology of the European quality audit of opioid treatment (EQUATOR) project. Heroin Addict Relat Clin Probl. 2012;14(3):5\u201370.","journal-title":"Heroin Addict Relat Clin Probl"},{"issue":"4","key":"109_CR36","first-page":"5","volume":"14","author":"I Maremmani","year":"2012","unstructured":"Maremmani I. Foreword\u2014EQUATOR publication series. Heroin Addict Relat Clin Probl. 2012;14(4):5\u20136.","journal-title":"Heroin Addict Relat Clin Probl"},{"issue":"4","key":"109_CR37","first-page":"51","volume":"14","author":"H St\u00f6ver","year":"2012","unstructured":"St\u00f6ver H. Assessing the current state of public-health-related outcomes in opioid dependence across Europe: data from the EQUATOR analysis. Heroin Addict Relat Clin Probl. 2012;14(4):51\u201364.","journal-title":"Heroin Addict Relat Clin Probl"},{"key":"109_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.12.021","volume":"161","author":"G Kourounis","year":"2016","unstructured":"Kourounis G, Richards BD, Kyprianou E, Symeonidou E, Malliori MM, Samartzis L. Opioid substitution therapy: lowering the treatment thresholds. Drug Alcohol Depend. 2016;161:1\u20138.","journal-title":"Drug Alcohol Depend"},{"key":"109_CR39","doi-asserted-by":"crossref","unstructured":"Amato L, Minozzi S, Davoli M, Vecchi S. Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. Cochrane Database Syst Rev. 2011;9:CD005031. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21901695 .","DOI":"10.1002\/14651858.CD005031.pub4"},{"key":"109_CR40","volume-title":"DAH-Q: drug addiction questionnaire","author":"I Maremmani","year":"1989","unstructured":"Maremmani I, Castrogiovanni P. DAH-Q: drug addiction questionnaire. Pisa: University Press; 1989."},{"key":"109_CR41","first-page":"182","volume-title":"Psychiatry diagnosis and terapy","author":"HW Lahmeyer","year":"1988","unstructured":"Lahmeyer HW, Channon RA, Schlemmer FJ. Psychoactive substance abuse. In: Flaherty JA, Channon RA, Devis JM, editors. Psychiatry diagnosis and terapy. San Mateo: Appleton & Lange; 1988. p. 182\u201399."},{"issue":"3","key":"109_CR42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0740-5472(98)00031-2","volume":"16","author":"T Blaney","year":"1999","unstructured":"Blaney T, Craig RJ. Methadone maintenance. Does dose determine differences in outcome? J Subst Abuse Treat. 1999;16(3):221\u20138.","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"109_CR43","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1371\/journal.pmed.0030080","volume":"3","author":"JA Trafton","year":"2006","unstructured":"Trafton JA, Minkel J, Humphreys K. Determining effective methadone doses for individual opioid-dependent patients. PLos Med. 2006;3(3):e80.","journal-title":"PLos Med"},{"issue":"1\u20132","key":"109_CR44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.drugalcdep.2008.11.006","volume":"101","author":"DH Epstein","year":"2009","unstructured":"Epstein DH, Schmittner J, Umbricht A, Schroeder JR, Moolchan ET, Preston KL. Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency. Drug Alcohol Depend. 2009;101(1\u20132):92\u2013100.","journal-title":"Drug Alcohol Depend"},{"key":"109_CR45","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1747-597X-9-46","volume":"9","author":"M Baumeister","year":"2014","unstructured":"Baumeister M, Vogel M, Dursteler-MacFarland KM, Gerhard U, Strasser J, Walter M, Wiesbeck GA, Petitjean SA. Association between methadone dose and concomitant cocaine use in methadone maintenance treatment: a register-based study. Subst Abuse Treat Prev Policy. 2014;9:46.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1","key":"109_CR46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2105\/AJPH.85.1.83","volume":"85","author":"DM Hartel","year":"1995","unstructured":"Hartel DM, Schoenbaum EE, Selwyn PA, Kline J, Davenny K, Klein RS, Friedland GH. Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. Am J Public Health. 1995;85(1):83\u20138.","journal-title":"Am J Public Health"},{"issue":"3","key":"109_CR47","first-page":"393","volume":"100","author":"F Kamal","year":"2007","unstructured":"Kamal F, Flavin S, Campbell F, Behan C, Fagan J, Smyth R. Factors affecting the outcome of methadone maintenance treatment in opiate dependence. Ir Med J. 2007;100(3):393\u20137.","journal-title":"Ir Med J"},{"issue":"1","key":"109_CR48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1300\/J069v26n01_08","volume":"26","author":"I Maremmani","year":"2007","unstructured":"Maremmani I, Pani PP, Mellini A, Pacini M, Marini G, Lovrecic M, Perugi G, Shinderman M. Alcohol and cocaine use and abuse among opioid addicts engaged in a methadone maintenance treatment program. J Addict Dis. 2007;26(1):61\u201370.","journal-title":"J Addict Dis"},{"issue":"1","key":"109_CR49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2003.11.017","volume":"75","author":"G Gerra","year":"2004","unstructured":"Gerra G, Borella F, Zaimovic A, Moi G, Bussandri M, Bubici C, Bertacca S. Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome. Drug Alcohol Depend. 2004;75(1):37\u201345.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"109_CR50","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1360-0443.2003.00310.x","volume":"98","author":"DH Epstein","year":"2003","unstructured":"Epstein DH, Preston KL. Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? Past findings and more evidence against. Addiction. 2003;98(3):269\u201379.","journal-title":"Addiction"},{"issue":"1","key":"109_CR51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.drugalcdep.2004.01.009","volume":"75","author":"ML Willenbring","year":"2004","unstructured":"Willenbring ML, Hagedorn HJ, Postier AC, Kenny M. Variations in evidence-based clinical practices in nine United States Veterans Administration opioid agonist therapy clinics. Drug Alcohol Depend. 2004;75(1):97\u2013106.","journal-title":"Drug Alcohol Depend"},{"key":"109_CR52","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/jama.1965.03090080008002","volume":"193","author":"VP Dole","year":"1965","unstructured":"Dole VP, Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride. JAMA. 1965;193:646\u201350.","journal-title":"JAMA"}],"updated-by":[{"DOI":"10.1186\/s12991-017-0132-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T00:00:00Z","timestamp":1486944000000}}],"container-title":["Annals of General Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12991-016-0109-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T00:30:13Z","timestamp":1498350613000},"score":1,"resource":{"primary":{"URL":"http:\/\/annals-general-psychiatry.biomedcentral.com\/articles\/10.1186\/s12991-016-0109-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,25]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["109"],"URL":"https:\/\/doi.org\/10.1186\/s12991-016-0109-z","relation":{},"ISSN":["1744-859X"],"issn-type":[{"value":"1744-859X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,25]]},"article-number":"34"}}